Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

JPM 2016: Cipla Shapes Respiratory Build-Up

This article was originally published in PharmAsia News

Executive Summary

Around a quarter of Cipla's top 50 R&D projects currently underway are in the respiratory segment and the Indian firm says it aims to launch its own differentiated respiratory and oncology pipeline in the US in the "near future."

Advertisement

Related Content

Cipla 2.0: ‘Disproportionate’ US Growth, Getting The Profit Curve Right

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register